MetLife Investment Management’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4M Sell
18,300
-2,429
-12% -$531K 0.02% 675
2025
Q1
$4.64M Sell
20,729
-383
-2% -$85.7K 0.03% 647
2024
Q4
$6.92M Buy
21,112
+243
+1% +$79.6K 0.04% 395
2024
Q3
$6.26M Sell
20,869
-599
-3% -$180K 0.04% 421
2024
Q2
$7.07M Buy
21,468
+1,084
+5% +$357K 0.04% 335
2024
Q1
$8.07M Sell
20,384
-626
-3% -$248K 0.05% 292
2023
Q4
$7.4M Sell
21,010
-344
-2% -$121K 0.05% 305
2023
Q3
$8.01M Sell
21,354
-566
-3% -$212K 0.06% 255
2023
Q2
$8.38M Sell
21,920
-140
-0.6% -$53.5K 0.06% 254
2023
Q1
$7.64M Sell
22,060
-221
-1% -$76.6K 0.06% 280
2022
Q4
$5.24M Sell
22,281
-445
-2% -$105K 0.04% 409
2022
Q3
$5.59M Sell
22,726
-260
-1% -$64K 0.05% 358
2022
Q2
$6.95M Sell
22,986
-445
-2% -$135K 0.05% 281
2022
Q1
$9.62M Buy
23,431
+7,064
+43% +$2.9M 0.06% 257
2021
Q4
$7.68M Sell
16,367
-342
-2% -$160K 0.06% 254
2021
Q3
$7.09M Sell
16,709
-407
-2% -$173K 0.06% 254
2021
Q2
$6.15M Sell
17,116
-543
-3% -$195K 0.05% 301
2021
Q1
$4.98M Sell
17,659
-295
-2% -$83.1K 0.05% 389
2020
Q4
$5.09M Sell
17,954
-769
-4% -$218K 0.05% 353
2020
Q3
$5.15M Sell
18,723
-527
-3% -$145K 0.06% 310
2020
Q2
$4.37M Sell
19,250
-23,222
-55% -$5.28M 0.05% 350
2020
Q1
$6.47M Hold
42,472
0.09% 190
2019
Q4
$6.38M Sell
42,472
-423
-1% -$63.6K 0.07% 263
2019
Q3
$6.08M Sell
42,895
-642
-1% -$91K 0.07% 270
2019
Q2
$5.45M Sell
43,537
-1,684
-4% -$211K 0.06% 314
2019
Q1
$4.98M Buy
45,221
+51
+0.1% +$5.62K 0.05% 339
2018
Q4
$4.43M Buy
45,170
+148
+0.3% +$14.5K 0.05% 332
2018
Q3
$5.56M Sell
45,022
-1,222
-3% -$151K 0.06% 324
2018
Q2
$4.59M Buy
46,244
+73
+0.2% +$7.25K 0.05% 345
2018
Q1
$4.08M Sell
46,171
-810
-2% -$71.5K 0.05% 426
2017
Q4
$4.64M Buy
+46,981
New +$4.64M 0.05% 372